November 23 | 2018
2cureX AB publishes interim report for January – September 2018
Read more
November 23 | 2018
2cureX AB offentliggör delårsrapport för januari – september 2018
Read more
November 16 | 2018
Vejle universitetssjukhus och 2cureX har erhållit godkännande att inleda en klinisk studie i bukspottkörtelcancer
Read more
November 16 | 2018
The University Hospital, Vejle Hospital and 2cureX have received approval to start a clinical trial in pancreatic cancer
Read more
October 23 | 2018
Poster presentation at ESMO 2018 in Munich
Read more
October 23 | 2018
Presentation av poster vid ESMO 2018 i München
Read more
October 18 | 2018
Article from BioStock
Read more
October 18 | 2018
Artikel från BioStock
Read more
October 9 | 2018
2cureX announces CE-IVD marking of its IndiTreat test
Read more
October 9 | 2018
2cureX meddelar godkänd CE-IVD-märkning av sitt IndiTreat-test
Read more
October 3 | 2018
Add. info to newsletter ”2cureX GmbH receives contribution for the development of IndiTreat® tests in immuno-oncology”
Read more
October 3 | 2018
2cureX tyska dotterbolag erhåller bidrag för utveckling av IndiTreat®-test inom immunonkologi
Read more
September 12 | 2018
Meet us at Sedermeradagen in Göteborg
Read more
September 12 | 2018
Möt oss på Sedermeradagen i Göteborg
Read more
August 24 | 2018
2cureX AB offentliggör halvårsrapport för det första halvåret 2018
Read more
August 24 | 2018
2cureX AB publishes interim report for the first half-year of 2018
Read more
August 22 | 2018
2cureX stärker sin patentportfölj med nytt godkänt europeiskt patent
Read more
August 22 | 2018
2cureX strengthen its patent portfolio with the granting of a new European patent
Read more